BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26003080)

  • 1. Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: involvement of the INSIG/SREBP pathway.
    Dang R; Jiang P; Cai H; Li H; Guo R; Wu Y; Zhang L; Zhu W; He X; Liu Y; Xu P
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1239-47. PubMed ID: 26003080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential mechanism underlying atypical antipsychotics-induced lipid disturbances.
    Cai HL; Tan QY; Jiang P; Dang RL; Xue Y; Tang MM; Xu P; Deng Y; Li HD; Yao JK
    Transl Psychiatry; 2015 Oct; 5(10):e661. PubMed ID: 26485545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model.
    Boyda HN; Tse L; Procyshyn RM; Wong D; Wu TK; Pang CC; Barr AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):945-54. PubMed ID: 20452386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells.
    Chen CC; Hsu LW; Huang KT; Goto S; Chen CL; Nakano T
    Sci Rep; 2017 Sep; 7(1):10901. PubMed ID: 28883496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of ω-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway.
    Tang M; Floyd S; Cai H; Zhang M; Yang R; Dang R
    Food Funct; 2019 Aug; 10(8):4649-4660. PubMed ID: 31292598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic polypharmacy increases metabolic dysregulation in female rats.
    Boyda HN; Procyshyn RM; Tse L; Xu J; Jin CH; Wong D; Pang CC; Honer WG; Barr AM
    Exp Clin Psychopharmacol; 2013 Apr; 21(2):164-71. PubMed ID: 23356730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats.
    Liu X; Wu Z; Lian J; Hu CH; Huang XF; Deng C
    Sci Rep; 2017 Jun; 7(1):2762. PubMed ID: 28584269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats.
    Rezvani AH; Caldwell DP; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.
    Houseknecht KL; Robertson AS; Zavadoski W; Gibbs EM; Johnson DE; Rollema H
    Neuropsychopharmacology; 2007 Feb; 32(2):289-97. PubMed ID: 17035934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.
    Lin EJ; Lee NJ; Slack K; Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I; Herzog H; Sainsbury A
    Neuropharmacology; 2006 Dec; 51(7-8):1129-36. PubMed ID: 16919686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the atypical antipsychotics clozapine, remoxipride and risperidone on the contractile characteristics of rat skeletal muscle in vitro.
    Mendes LS; Collins SP
    Pharmacol Res; 1997 Dec; 36(6):457-61. PubMed ID: 9446712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells.
    Hu Y; Kutscher E; Davies GE
    Phytother Res; 2010 Dec; 24(12):1831-8. PubMed ID: 20564506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sex-dependent impact of chronic clozapine and haloperidol treatment on characteristics of the metabolic syndrome in a rat model.
    von Wilmsdorff M; Bouvier ML; Henning U; Schmitt A; Schneider-Axmann T; Gaebel W
    Pharmacopsychiatry; 2013 Jan; 46(1):1-9. PubMed ID: 22915487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
    de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
    Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of atypical antipsychotics on metabolism].
    Bakos CD; Berecz R; Degrell I
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):86-9. PubMed ID: 15787207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.
    Sondhi S; Castellano JM; Chong VZ; Rogoza RM; Skoblenick KJ; Dyck BA; Gabriele J; Thomas N; Ki K; Pristupa ZB; Singh AN; MacCrimmon D; Voruganti P; Foster J; Mishra RK
    Pharmacogenomics J; 2006; 6(2):131-40. PubMed ID: 16402076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.